Walvax Biotechnology Co., Ltd. (300142.SZ) SHZ

10.91

-0.16(-1.45%)

Updated at December 31 03:04PM

Currency In CNY

Valuation

Market Cap19.32B
Enterprise Value16B
P/E Ratio354.33
PEG Ratio1.51
Price/Sales Ratio7.27
Price/Book Ratio1.8
Enterprise/Revenue6.69
Enterprise/EBITDA322.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.02
Operating Margin-0.06

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue2.82B
Revenue/Share1.5
Gross Profit2.08B
EBITDA387.61M
Net Income142.16M
Diluted EPS0.09

Balance Sheet

Total Cash1.68B
Total Cash/Share1.05
Total Debt272.24M
Total Debt/Equity0.03
Current Ratio3.52
Book Value Per Share6.84

Price History

52-Week Change-9.69
52-Week High14.25
52-Week Low9.7
Moving Average 50 Days11.83
Moving Average 200 Days11.52

Statistics

Average Volume29.03M
Shares Outstanding1.6B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.01
Trailing Annual Dividend Yield0.09
Payout Ratio0.77
Last Split Factor3:1
Last Split DateNovember 10, 2015